Autoplaque vs Vivid T8

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

Vivid T8

by GE HealthCare

AI Verdict

Autoplaque is an AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction. In contrast, the GE Vivid T8 is a hybrid cardiovascular ultrasound system with advanced imaging capabilities and AI-based tools for workflow efficiency. While both are used in cardiology and leverage AI, Autoplaque focuses on CT-based plaque analysis, whereas the Vivid T8 provides comprehensive ultrasound imaging and AI-assisted measurements for a broader range of cardiac functions.

Choose Autoplaque if…

Choose Autoplaque if your primary need is detailed, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for cardiologists and radiologists seeking to precisely characterize atherosclerotic plaque, measure stenosis, and aid in heart attack risk prediction and treatment guidance based on CT data.

View Autoplaque →

Choose Vivid T8 if…

Choose the GE Vivid T8 if you require a versatile, cost-effective hybrid cardiovascular ultrasound system for both cardiac and shared services. This system is well-suited for diverse clinical settings where advanced imaging capabilities, including AI-based workflow efficiency tools, are needed for comprehensive cardiovascular scanning and general internal medicine applications.

View Vivid T8 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	Vivid T8
Pricing	Unknown	Contact vendor
Deployment	Workstation-based post-processing application, runs on Windows or Mac OS.	On-premise (console-based medical device)
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Vivid T8

The GE Vivid T8 is designed with an intuitive user interface, including touch-screen capabilities, rotary dials, and patient management buttons, aiming for ease of use and a familiar 'Vivid console' feel. It also offers a customizable user interface and is built for mobility, making it adaptable to various clinical environments. Autoplaque is workstation-based software, and while it offers reviewable and editable segmentations, there is less specific information regarding its overall user experience and interface design beyond its functionality.

Clinical Value

Autoplaque

Autoplaque provides AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, directly aiding in heart attack risk prediction and treatment guidance. This offers a direct and specific clinical benefit in a critical area of cardiovascular health. The Vivid T8, while a robust ultrasound system with advanced quantitative tools and AI for workflow efficiency, is a broader diagnostic imaging tool, and its AI features primarily focus on streamlining existing ultrasound workflows rather than providing a novel diagnostic output like plaque characterization for risk prediction.

Pricing & Value

Vivid T8

GE HealthCare's Vivid T8 offers transparent pricing for refurbished units starting at $22,800 and includes 3 years of service coverage, providing a clear understanding of the initial investment and ongoing support. Autoplaque's pricing is not disclosed, making it difficult for potential buyers to assess its overall value proposition without direct vendor contact.

Enterprise Readiness

Tie

Both tools demonstrate aspects of enterprise readiness. Autoplaque is FDA-cleared and can run on standard computer platforms (Windows or Mac), suggesting flexibility in deployment within existing IT infrastructures. The Vivid T8 is also FDA-cleared, is a console-based medical device, and supports DICOM and EchoPAC compatibility for image analysis and sharing, indicating its ability to integrate into clinical workflows. However, specific details on broader enterprise-level features like scalability, security protocols beyond basic HIPAA compliance (which is mentioned for Vivid T8's usage context), or integration with various PACS systems are not extensively detailed for either product in the provided information.

Innovation

Autoplaque

Autoplaque stands out for its innovative application of AI in providing quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, directly contributing to heart attack risk prediction. This represents a distinct advancement in diagnostic capabilities. While the Vivid T8 Ultra Edition incorporates AI for workflow efficiency in ultrasound, this is more of an enhancement to existing technology rather than a fundamentally new diagnostic approach.

Support & Docs

Vivid T8

GE HealthCare provides extensive documentation for the Vivid T8, including user manuals and service manuals, which are readily available and detail operation and maintenance. They also offer a 'Vivid Club' for users and a clinical answer center for support. For Autoplaque, while user manuals are mentioned for hardware specifications, there is less public information available regarding the breadth and accessibility of its support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	Vivid T8
Name	Autoplaque	Vivid T8
Company	Cedars-Sinai Medical Center: AIM	GE HealthCare
Description	Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.	The GE Vivid T8 is a hybrid cardiovascular ultrasound system offering advanced imaging capabilities for cardiac and shared services, designed for reliability and ease of use in diverse clinical settings. It includes AI-based tools for workflow efficiency in its Ultra Edition.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI
Key Features	AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area	Hybrid cardiovascular and shared-service ultrasound capabilities; 19-inch LCD monitor (21.5-inch for Ultra Edition) and 8.4-inch LCD touchscreen (10.1-inch multi-touch for Ultra Edition); 4 active transducer ports; Advanced quantitative tools (e.g., Tissue Velocity Imaging, AutoEF, SmartStress, AFI, Strain/Strain Rate Imaging, AutoIMT); Rugged, durable, and mobile design with extensive stress testing; AI-based tools for workflow efficiency (Vivid T8 Ultra Edition); DICOM and EchoPAC compatibility for image analysis and sharing; Comprehensive cardiovascular scanning applications

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and Vivid T8.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for cardiologists and radiologists?

Autoplaque is a workstation-based post-processing application designed for cardiologists and radiologists to view and analyze cardiac CT data for coronary plaque and stenosis. It functions as an interactive tool and can serve as a second reader and clinical decision support tool in routine CCTA workflows. The GE Vivid T8, a hybrid ultrasound system, aims to improve workflow efficiency with AI-based tools that reduce manual steps and automate processes, such as Cardiac Auto-Doppler and 2D-LV measurements. It also offers compatibility with DICOM and EchoPAC for image analysis and sharing, and can integrate with GE Healthcare Centricityu2122 Cardio Enterprise and ViewPointu2122 6.

What is the accuracy and sensitivity of each tool in detecting and characterizing cardiac conditions?

Autoplaque provides AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction. It has shown high agreement (0.95 ICC) with intravascular ultrasound (IVUS) for plaque quantification and has been validated in multicenter studies. The Vivid T8 Ultra Edition utilizes AI-based tools for automated measurements like ejection fraction (AutoEF) and global and segmental strain, aiming for high accuracy and reproducibility. Its AI-based Cardiac Auto-Doppler provides Doppler measurements over all heart cycles for common parameters, supporting consistent results.

What is the learning curve for physicians and sonographers using these tools?

Autoplaque is intended for use by trained medical professionals, including radiologists and cardiologists, who have been appropriately trained in its functions, capabilities, and limitations. The Vivid T8 is designed for ease of use with an intuitive user interface, touchscreen capabilities, and simplified Vivid software, which can lead to a faster staff ramp-up. Its AI-based tools are specifically designed to reduce tedious tasks and manual steps, potentially shortening examination times and making it easier to learn.

What kind of customer support and resources are available for these tools?

GE HealthCare offers 3 years of service coverage with the Vivid T8, which includes on-site maintenance and remote support. They also provide access to the Vivid Club, an online community for cardiologists, echocardiologists, and sonographers, offering learning opportunities and resources. The Vivid T8 also supports remote software updates and safety patches. Information regarding Autoplaque's specific customer support structure is not detailed, but it is exclusively licensed by APQ Health, a startup focused on transforming this innovation into physician-ready tools.

What are the clinical implications and time-to-value for incorporating these tools into a practice?

Autoplaque provides automated, objective results for coronary plaque analysis, which can reduce interobserver variability and interpretative error, enhancing risk stratification for future cardiac events. This can lead to a faster prognosis and potentially guide personalized therapeutic pathways. The Vivid T8's AI-based tools are designed to reduce manual steps and automate processes, which can lead to shorter examination times and increased productivity, allowing more time for patient interaction. This can result in a quick time-to-value by streamlining daily workflows and increasing diagnostic confidence.

What security features are in place beyond standard compliance to protect patient data?

The Vivid T8 is built and configured for reliability and security, including LDAP support for IT control over system access and configurable system passwords to reduce the risk of breaches. GE HealthCare also employs SonoDefense, a six-layer strategic approach to cybersecurity and patient data privacy for ultrasound. Information regarding Autoplaque's specific security posture beyond HIPAA is not detailed in the provided information.

Are there any customer references or clinical studies available to support the effectiveness of these tools?

Autoplaque is backed by over 100 peer-reviewed publications and has been involved in multicenter, international trials such as SCOT-HEART, RAPID-CTCA, and PACIFIC. Studies have shown its ability to quantify plaque as effectively as trained doctors and its association with future non-ST-elevation myocardial infarction. The Vivid T8 has testimonials from cardiologists and sonographers highlighting its ability to improve workflow efficiency, diagnostic confidence, and reduce inter-operator variability. GE HealthCare also provides a Vivid Club for community resources and learning opportunities.